Affiliation: University of Liverpool
- Focus on olanzapineB Green
University Department of Psychiatry, Royal Liverpool University Hospital, University of Liverpool, UK
Curr Med Res Opin 15:79-85. 1999..Olanzapine's general efficacy and side-effect profile suggest that, unforeseen post-marketing complications notwithstanding, olanzapine deserves a major place in the first-line management of psychotic disorders...
- Lamotrigine in mood disordersBen Green
Department of Psychiatry, University of Liverpool, UK
Curr Med Res Opin 19:272-7. 2003..Further research is certainly warranted and, given its tolerability, could point to lamotrigine as the treatment of choice for some affective disorders...
- Post-traumatic stress disorder: symptom profiles in men and womenBen Green
Department of Psychiatry, University of Liverpool and Royal Liverpool University Hospital, UK
Curr Med Res Opin 19:200-4. 2003..To investigate the symptom frequencies of a relatively large sample of post-traumatic stress disorder (PTSD) sufferers and compare male and female symptom profiles...
- Focus on paroxetineBen Green
North Cheshire Hospitals NHS Trust, Halton, Cheshire, UK
Curr Med Res Opin 19:13-21. 2003..A 3- or 4-week graded withdrawal regimen, perhaps with concomitant fluoxetine to cover serotonergic discontinuation symptoms, may be advisable...
- Focus on ziprasidoneB Green
Halton Hospital and the University of Liverpool, Liverpool, UK
Curr Med Res Opin 17:146-50. 2001..Reduced effects on cognitive abilities compared to conventional antipsychotics make ziprasidone more attractive still. Barring any unforeseen complications, it appears to a most valuable addition to the antipsychotic agents...
- Focus on risperidoneB Green
University of Liverpool, UK
Curr Med Res Opin 16:57-65. 2000..There is now adequate comparison with conventional antipsychotics to suggest its superiority, but a depot formulation is needed to complete the picture...
- Focus on aripiprazoleBen Green
Cheadle Royal Hospital, and Honorary Senior Lecturer, University of Liverpool, UK
Curr Med Res Opin 20:207-13. 2004..The dose may be adjusted at intervals of not less than 2 weeks up to a maximum of 30 mg daily. It appears to be useful in disorder and has a better side-effect profile than haloperidol...
- Focus on agomelatineBen Green
Cheadle Royal Hospital, Cheadle, Cheshire, UK
Curr Med Res Opin 27:745-9. 2011..Agomelatine is a novel antidepressant with agonist activity at melatonin receptors (MT(1) and MT(2)), and antagonistic effects at the 5HT(2c) serotonin receptor...
- Focus on levomepromazineBen Green
Cheadle Royal Hospital, Department of Psychiatry, University of Liverpool, UK
Curr Med Res Opin 20:1877-81. 2004..Some antimycobacterial properties have been recorded. The drug should not be prescribed to patients at high risk of accidental or suicidal overdose...
- Zotepine: a clinical reviewBen Green
Cheadle Royal Hospital, Cheshire, UK
Expert Opin Drug Metab Toxicol 5:181-6. 2009..There are some open label studies suggesting usefulness in treatment resistant schizophrenia, but larger, double-blind studies are required...
- Focus on amisulprideBen Green
University of Liverpool, UK
Curr Med Res Opin 18:113-7. 2002..There are interesting studies that point towards amisulpride's antidepressant effect in dysthymia speculative on possible roles in affective psychoses and chronic fatigue syndrome...
- Post-traumatic stress disorder in UK police officersBen Green
University of Liverpool Department of Psychiatry, and Cheadle Royal Hospital, 100 Wilmslow Road, Cheadle, Cheshire SK8 3DG, UK
Curr Med Res Opin 20:101-5. 2004..Police officers had more experiences of reliving the trauma or acting as if the trauma were recurring but, again, not to a significant degree...
- Key developments in psychiatryBen Green
Cheadle Royal Hospital, University of Liverpool
Practitioner 248:387-90. 2004